Abstract
The objective of the present study was to develop a self micro-emulsifying drug delivery system (SMEDDS) of chlorthalidone (CTD) to improve its solubility and dissolution. CTD is a diuretic agent belongs to Biopharmaceutics classification system (BCS)-IV category having poor solubility and permeability. Solubility study of CTD was carried out in various excipients. Based on solubility study, Capmul MCM as oil, Tween 80 as surfactant and PEG 400 as co-surfactant were selected as a component of liquid SMEDDS formulation. The pseudo-ternary phase diagram was constructed to identify the optimum composition of the formulation. The optimum formulation showed emulsification time 42 ± 3.3 s, cloud point 72 ± 2 °C, globule size 174.2 ± 1.1 nm and zeta potential −9.92 ± 1.2 mV. The optimized SMEDDS formulation was transferred on to the inert adsorbent i.e. Neusilin US2, to formed a solid self emulsifying drug delivery system (S-SMEDDS). Solid SMEDDS with 1:1 ratio (adsorbent: SMEDDS) showed excellent oil adsorption capacity, low bulk density and good flow properties. Furthermore, DSC, PXRD and SEM studies indicated the transformation of crystalline structure of CTD to amorphous and molecularly dissolved state. In vitro dissolution study indicates high dissolution rate of solid-SMEDDS over the pure drug and marketed formulation. Thus, SMEDDS formulation helps to improve the solubility and dissolution of CTD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
